BWX Technologies reported second quarter 2026 results with revenues of $901.6 million and net income of $89.1 million, or diluted GAAP EPS of $0.97. The company raised its full-year adjusted EBITDA guidance to $662 million-$672 million and non-GAAP EPS guidance to $4.70-$4.80. BWXT announced the sale of its medical business to focus on core nuclear markets and closed the acquisition of Precision Components Group, LLC on July 1, 2026. The Board declared a quarterly cash dividend of $0.27 per share, payable September 4, 2026, to shareholders of record on August 18, 2026. BWX Technologies operates in the nuclear energy and defense sector, providing manufacturing and engineering solutions for national security and commercial power.